• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, COSTA RICA LTDA (SH) TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, COSTA RICA LTDA (SH) TRIFECTA GT VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TFGT-21A
Device Problems Backflow (1064); Material Split, Cut or Torn (4008)
Patient Problem Aortic Regurgitation (1716)
Event Date 12/01/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2018, a 21mm trifecta gt valve was implanted.In (b)(6) 2020, severe aortic regurgitation was observed and on (b)(6) 2020, the trifecta gt valve was explanted.Upon explant, a tear on the base from the rcc to the ncc was observed.A new 19mm trifecta gt valve was successfully implanted.The patient was reported to be in stable condition.
 
Manufacturer Narrative
Additional information sections: d9, h2, h3, h6, h10.Explant was reported due to regurgitation and upon explant a tear was noted.The investigation confirmed that a tear was present in leaflet 1 which extended into leaflet 2.Leaflets 2 and 3 contained calcifications.Stent posts 2 and 3 were bent outward.No acute inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.This was inclusive of a review of the manufacturing videos, which contained no evidence of anomalies or bent posts during functional inspection.Two outwardly bent stent posts were found.An outward bent stent post may result in a localized increase in leaflet stress which may potentially contribute to the leaflet tear, however it could not be conclusively determined whether the observed stent deformation occurred before or after valve explant making it difficult to determine the exact cause of the torn leaflets.The observed biological degeneration of the collagen at the tear site likely contributed to the observed torn leaflets.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIFECTA GT VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, COSTA RICA LTDA (SH)
parque industrial, zona franca coyol s.a.
edificio #44b, calle 0, avenida 2, coyol
alajuela, costa rica 01897 -405
CS  01897-4050
MDR Report Key10971723
MDR Text Key220395991
Report Number3008452825-2020-00684
Device Sequence Number1
Product Code LWR
UDI-Device Identifier05415067018212
UDI-Public05415067018212
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/21/2021
Device Model NumberTFGT-21A
Device Catalogue NumberTFGT-21A
Device Lot Number6242184
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/14/2020
Was the Report Sent to FDA? No
Date Manufacturer Received01/18/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age75 YR
-
-